Rainmed Medical Limited (HKG:2297)

Market Cap	196.19M -51.7%
Revenue (ttm)	27.06M +0.4%
Net Income	-77.24M
EPS	-0.06
Shares Out	1.40B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,000
Open	0.1450
Previous Close	0.1450
Day's Range	0.1400 - 0.1450
52-Week Range	0.1350 - 0.3300
Beta	0.60
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Rainmed Medical

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instruments related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system; FlashAngio caIMR System, which provides ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 208
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2297

Financial Performance

In 2025, Rainmed Medical's revenue was 19.18 million, a decrease of -51.85% compared to the previous year's 39.82 million. Losses were -77.08 million, -32.08% less than in 2024.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error